Research Type: Extramural
This project would be a significant step forward in development of personalised treatments and should improve survival for this aggressive cancer.
The ultimate goal of the project is to inform appropriate care and improve outcomes for pregnant women with cancer and their babies.
This project will develop vital infrastructure that will make it easier for clinicians to choose the right treatment for individual patients.
This project will test and validate how new technologies could be utilised to monitor the concentration of chemotherapy in a patient’s blood in real-time.
If this treatment is shown to be effective, it will provide much-needed hope for patients who receive the devastating diagnosis of pancreatic cancer.
Prof David Gottlieb’s research has discovered that the treatment of using enhanced white blood cells to fight infection and leukemia can reduce side effects in bone marrow transplant recipients.
A team of researchers led by Dr Nicole Verrills has been investigating if a new ‘gene marker’ can predict which breast cancer patients may have poorer treatment outcomes.
Shirley Baxter talks about representing consumers in deciding what research Cancer Council funds.
Researchers at Cancer Council NSW have conducted an Australian-first study that estimated future bowel cancer rates and deaths.
Dr Lionel Hebbard and his team conducted a long-range study that aimed to quantify the exact impact of metabolic drivers, particularly obesity, on liver cancer prognosis and progression in patients.